Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global methyl salicylate market attained a value of USD 334.20 Million in 2025 and is projected to expand at a CAGR of 5.60% through 2035. The market is further expected to achieve USD 576.30 Million by 2035. Rising demand for topical formulations targeting muscle and joint discomfort is supporting methyl salicylate consumption. The compound is widely incorporated into creams, gels, ointments, and patches because of its counterirritant properties, while growing use of OTC pain-management products is expanding its pharmaceutical application base.
Expansion of topical pain-relief formulations is anticipated to push the methyl salicylate market to new heights, supported by its use in creams, balms, ointments, lotions, and other formulations for temporary relief of muscle and joint pain. Growing utilization across oral care, personal care, fragrance, and flavoring applications is also broadening its demand base. Methyl salicylate is used in mouthwashes and toothpastes, while fragrance applications benefit from its characteristic wintergreen profile. This application diversification is encouraging manufacturers to develop high-purity, application-specific grades and strengthen supply capabilities for pharmaceutical and consumer-product formulators globally, thereby boosting the methyl salicylate market value.
In June 2025, researchers proposed using methyl salicylate (MeSA)-loaded microspheres for controlled-release pest management. The approach encapsulates MeSA and deploys it on plant leaves, enabling controlled volatilization that can help deter pests and attract beneficial insects. The research also developed release-kinetic and coverage models to optimize microsphere placement under different wind conditions. This development expands methyl salicylate’s potential beyond pharmaceutical, personal care, flavor, and fragrance uses into sustainable agricultural applications. By enabling targeted and controlled delivery, the technology could support lower-input pest management while creating an emerging downstream application for methyl salicylate producers
Tightening safety and regulatory requirements, particularly for cosmetic and consumer applications, is a significant challenge that is affecting market growth. The European Commission’s SCCS has highlighted concerns regarding systemic exposure, skin sensitization, and use in products intended for children, with specific concentration limits established for certain applications. Players can overcome this challenge by strengthening toxicological testing, maintaining rigorous quality-control systems, developing application-specific grades, and continuously monitoring regulatory changes across major markets. Manufacturers can also provide detailed safety documentation and technical support to formulators, enabling customers to meet concentration requirements while maintaining product performance and reducing regulatory risks, thus aiming more towards the methyl salicylate market developments.
Compound Annual Growth Rate
5.6%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
SK Chemicals launched the Trast Coin Plaster, a coin-sized OTC pain-relief patch containing methyl salicylate for targeted topical pain management. Measuring 2.8 cm, the compact format supports convenient application and portability, potentially expanding methyl salicylate demand through innovative, consumer-focused analgesic formulations and strengthening its pharmaceutical market applications.
Sanofi Consumer Healthcare India introduced Combiflam MS Cream, formulated with methyl salicylate, menthol, and camphor for topical pain relief. In August 2025, the brand also promoted the product through its “Charan Vandana” initiative at Mumbai’s Lalbaugcha Raja. The launch expands methyl salicylate use in consumer-oriented pain-relief formulations and strengthens its visibility in India’s OTC market, boosting the trends in the methyl salicylate market.
Florrax Pharmaceutical’s Methyl Salicylate 10% Patch was documented in an updated U.S. DailyMed label in June 2025. The OTC external analgesic contains 10% methyl salicylate and is indicated for temporary relief of muscle and joint aches associated with strains, sprains, backache, arthritis, and bruises. The patch format highlights continued demand for convenient, targeted topical pain-relief delivery and supports methyl salicylate consumption in pharmaceutical formulations.
Researchers developed methyl salicylate-loaded microspheres for controlled release on plant leaves, targeting pest deterrence and beneficial-insect attraction. This innovation broadens methyl salicylate’s application base beyond pharmaceuticals, personal care, flavors, and fragrances, potentially creating new demand from sustainable agriculture and precision crop-protection formulations.
Pharmaceutical demand remains a major foundation for the methyl salicylate market. The ingredient is widely used in topical analgesic creams, patches, oils, and other formulations for temporary relief of minor muscle and joint aches and pains. Recent United States product activity demonstrates continued formulation demand. As per industry estimates, a methyl salicylate 25% topical patch with a marketing start date of February 2025, while multiple 25% methyl salicylate creams entered active marketing during 2025. These developments indicate continued use of methyl salicylate in convenient topical dosage forms and support demand for pharmaceutical-grade material with consistent specifications, thus affecting the methyl salicylate market dynamics and trends.
Methyl salicylate needs to be supplied in high quality with proper documentation and well-defined specifications by the pharmaceutical, oral care, and personal care industries. The suppliers, therefore, are focusing on pharmaceutical, premium, and application-based grades instead of just relying on the quantity of the product. Seqens provides pharmaceutical and Premium Plus methyl salicylate, with the latter being designed for oral care, mouth washes, toothpastes, flavoring, soothing, and oral hygiene uses. Seqens says that their premium plus and pharmaceutical grades are Kosher & Halal approved, and FDA registered and HACCP, USP, and European Pharmacopeia compliant.
There is another avenue in the diversification of the market in addition to the use of topical pain relievers. The reason methyl salicylate is incorporated into mouthwashes, and toothpaste is due to its unique taste and functionality. Seqens manufactures methyl salicylate with a concentration of 150-ppm for oral care and it is described by them as colourless and with ultra-low impurities and water levels. Similarly, Jindal Drugs also gives different uses of methyl salicylate in oral care, flavor & fragrances, confectioneries, aromatherapy and pharmaceutical and healthcare products, thereby boosting the trends in the methyl salicylate market.
Applications of methyl salicylate in fragrances and personal care are still in place due to its distinctive wintergreen scent and usefulness in the production of fragrances and intermediates. The firm Seqens has noted that methyl salicylate is used in fragrances and is a key intermediate for the formation of other esters by transesterification. Methyl salicylate is offered by Seqens for the application in various personal care segments and specifically for the manufacturing of fragrances.
Reliable supply is increasingly important for pharmaceutical and personal-care formulators that require consistent quality and specifications. Vertically integrated manufacturing can strengthen supply continuity by providing greater control over production and quality. Seqens operates an integrated methyl salicylate production site in Roussillon, France, with stated methyl salicylate capacity of 6,000 tones, while offering pharmaceutical, Premium Plus, 150-ppm, and standard grades. Alta Laboratories also lists methyl salicylate in IP, BP, Ph.Eur., and USP-NF grades, with drum packaging for commercial supply. These capabilities support dependable sourcing and application-specific procurement across international markets.
The Expert Market Research’s report titled "Methyl Salicylate Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Application
Key Insight: The use of methyl salicylate has been growing in several different industries. The food and beverage industry employs methyl salicylate as a flavoring agent for candies, chewing gums, mints, and specific formulas, whereas the cosmetics and personal care industries find value in the distinct scent of wintergreen of methyl salicylate as well as its uses in oral care and perfumes. Methyl salicylate is still one of the major uses of the compound through its presence in topical pain relief creams, oils, liniments, and patches for the temporary relief of muscle and joint pains, thereby opening up new opportunities and boosting the growth of the methyl salicylate market.
Market Breakup by Region
Key Insight: The demand for methyl salicylate is growing across all the major regions driven by its usage in pharmaceuticals, personal care products, foods, flavors, and fragrances. In North America, growth can be attributed to the presence of the pharmaceutical and over-the-counter pain relief market. The growth in Europe is driven by specialty chemicals, fragrances, cosmetics and the need for high-quality grades. Asia Pacific will continue to be an important manufacturing and consuming region due to the presence of the chemical and pharmaceutical industries in China and India.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Pharmaceutical applications dominate methyl salicylate demand through widespread topical analgesic formulations and pain-relief products
Pharmaceuticals represent the dominant application for methyl salicylate, supported by its established use as an external analgesic in OTC products for temporary relief of minor muscle, joint, and musculoskeletal pain. It is incorporated into balms, creams, oils, ointments, lotions, and patches. Seqens offers dedicated Pharma EP/USP-grade methyl salicylate with a CEP regulatory package, highlighting the importance of quality-controlled material for pharmaceutical formulations. Continued development of convenient topical dosage forms further supports demand from pharmaceutical manufacturers and ingredient suppliers. Such developments will thus boost the methyl salicylate market dynamics and trends in the long run.
Cosmetics and personal care are gaining momentum as manufacturers diversify methyl salicylate applications beyond analgesics. The ingredient is used in oral-care formulations, particularly mouthwashes and toothpastes, while its characteristic profile supports fragrance-related applications. Seqens offers a specialized 150-ppm grade for oral care and identifies methyl salicylate for fragrance production and broader personal-care applications. Growing demand for specialized, high-purity ingredients and multifunctional formulation components is creating opportunities for suppliers to expand into higher-value cosmetic, oral-care, and fragrance markets.
North America dominates through established pharmaceuticals, OTC analgesics, and formulation capabilities.
The North America region holds the position of being a key area for methyl salicylate due to the presence of an advanced market for OTC pharmaceuticals along with high demand for topical analgesic formulations. There have been continuous developments in terms of product development on methyl salicylate creams and topical analgesics that have been introduced in the US for muscle and joint pain. Such factors are directly boosting the methyl salicylate market regional growth.
Asia Pacific is also positioned as a high-growth region as pharmaceutical manufacturing, personal-care production, oral-care demand, and specialty chemical consumption expand across China, India, Japan, and Southeast Asia. The region combines strong domestic consumption with extensive manufacturing and export capabilities, creating opportunities for methyl salicylate producers to serve pharmaceutical, flavor, fragrance, and personal-care formulators. Growing requirements for consistent, high-purity grades can further support value-added production, while established regional supply chains enable manufacturers to respond efficiently to both domestic and international demand.
Methyl salicylate market players are aiming to strengthen their position by improving product purity, consistency, production efficiency, and application-specific performance. Manufacturers are focusing on pharmaceutical-grade and high-purity methyl salicylate, while expanding supply capabilities for topical analgesics, personal care, fragrances, flavors, and industrial formulations. Reliable quality control and regulatory compliance are increasingly important for securing long-term B2B contracts.
Differentiation can be achieved through customized grades, flexible specifications, dependable delivery, and sustainable manufacturing practices. Methyl Salicylate companies can also strengthen competitiveness by investing in process optimization, vertically integrated raw-material sourcing, technical support, and application development. Geographic expansion and partnerships with pharmaceutical, cosmetic, and chemical formulators can further improve market access and customer retention.
Seqens Group, established in 2003 and headquartered in Écully, France, offers pharmaceutical-grade methyl salicylate manufactured at its Roussillon facility. Its portfolio includes Pharma, Premium Plus, 150 ppm, and Standard grades for pain relief, oral care, flavoring, fragrance, and personal care applications.
Zhenjiang Gaopeng Pharmaceutical Co., Ltd., based in Zhenjiang, Jiangsu, China, manufactures methyl salicylate in pharmaceutical and technical grades. Its product has 99.0–100.5% content and is supplied for pharmaceutical intermediates, solvents, perfumes, cosmetics, coatings, insecticides, and printing inks. The company has operated for approximately 25 years.
Alta Laboratories Ltd., founded in 1946 and headquartered in Mumbai, India, manufactures salicylates and specialty chemical ingredients serving pharmaceutical, pain-management, personal care, cosmetics, flavors, and fragrances applications. The company operates as a vertically integrated salicylates manufacturer, supported by cGMP-compliant production, quality laboratories, and tailored product specifications.
Tokyo Chemical Industry Co., Ltd. (TCI), established as a company in 1922 and commencing reagent operations in 1946, is headquartered in Tokyo, Japan. It offers methyl salicylate (Product No. S0015) with purity above 99.0% by GC, supplied primarily as a specialty organic chemical for laboratory and research applications.
Other methyl salicylate market key players include Siddharth Carbochem Products Ltd., among others.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Unlock opportunities in the global methyl salicylate market with Expert Market Research. Leverage market forecasts, competitive insights, and industry trends to identify emerging opportunities, strengthen market positioning, and make informed business decisions.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
The market is projected to grow at a CAGR of 5.60% between 2026 and 2035.
Key strategies include product innovation, capacity expansion, sustainable production, strategic partnerships, geographic expansion, high-purity grade development, and downstream formulation integration to strengthen competitiveness and address evolving pharmaceutical, personal care, and food applications.
The key trends guiding the growth of the market include emphasis on research and development activities for decreasing the risks of Hughes syndrome, strokes, and dementia, among patients and increasing population.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading applications in the market are food and beverages, cosmetics and personal care, and pharmaceuticals, among others.
The key players in the market include Seqens Group, Zhenjiang Gaopeng Pharmaceutical Co., Ltd., Alta Laboratories Ltd., Tokyo Chemical Industry Co., Ltd., and Siddharth Carbochem Products Ltd., among others.
In 2025, the market reached an approximate value of USD 334.20 Million.
The market is expected to attain approximately USD 576.30 Million by 2035.
Key challenges include fluctuating raw material prices, stringent safety and regulatory requirements, competition from alternative analgesic ingredients, supply-chain disruptions, counterfeit products, and rising compliance and production costs that can pressure manufacturer margins.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 2,499
USD 2,249
tax inclusive*
Single User License
One User
USD 3,999
USD 3,599
tax inclusive*
Five User License
Five User
USD 4,999
USD 4,249
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.